The Impact of Nafamostat Mesylate on the Prognosis of Patients With Sepsis-Induced Coagulopathy Undergoing Hemofiltration
Clinical trial NCT06994312 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06994312
- Sponsor
- The First Hospital of Jilin University
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-01
- Primary completion
- 2028-05-01
- Enrollment
- 282
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.